In addition, treatment with CM from Mφs remarkably reduced IL-10, IL-4 and TGF-β levels in NPC cells, which was reversed by SPLUNC1 deficiency, but intensified by SPLUNC1 overexpression (Supplementary Fig. 1C). This evidence concerns the gene IL4 and nasopharyngeal carcinoma.